Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer
ArticleAbstract: BACKGROUND. A common germline variant in HSD3B1(1245A>C) encodes for a hyperactive 3β-hydroxysteroidPalabras claves:Autores:Almassi N., Alyamani M., Berk M.P., Chien C., Emamekhoo H., Figg W.D., Garcia J., Grivas P.D., Hu B., Hwang T.H., Koshkin V.S., Mendiratta P., Park S., Peer C.J., Richard J. Auchus, Rini B., Sharifi N., Taylor J., Tyler A., Upadhyay S.K.Fuentes:scopusLow-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center
ArticleAbstract: Influenza morbidity and mortality can be severe and costly. Vaccination rates remain suboptimal in cPalabras claves:Cancer center, Immunization, influenza, quality improvement, VaccineAutores:Boonstra P.S., Cooney K.A., Devata S., Grivas P.D., Hernandez-Aya L., Ison M.G., Joseph Neil Spindel Eisenberg, Khoriaty R., McDonnell K., Ruch J., Silveira M., Smerage J., Wilfong J., Worden F.P.Fuentes:scopusIdentifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
ArticleAbstract: Purpose:We investigated the pathological response rates and survival associated with 3 vs 4 cycles oPalabras claves:drug administration schedule, neoadjuvant therapy, Survival, urinary bladder neoplasmsAutores:Barocas D.A., Bivalacqua T.J., Black P.C., Cookson M.S., Dall'Era M.A., Daneshmand S., Di Trapani E., Diego M. Carrión, Dinney C.P., D’Andrea D., Grivas P.D., Holzbeierlein J.M., Kassouf W., Lotan Y., McGrath J.S., Montgomery J.S., North S., Shariat S.F., Soria F., Spiess P.E., Sridhar S.S., Stephenson A.J., Thorpe A.C., van Rhijn B.W.G., Wright J.L., Zargar H.Fuentes:scopus